ロード中...
Inhibitory Effects of a Novel PPAR-γ Agonist MEKT1 on Pomc Expression/ACTH Secretion in AtT20 Cells
Although therapeutic effects of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists rosiglitazone and pioglitazone against Cushing's disease have been reported, their effects are still controversial and inconsistent. We therefore examined the effects of a novel PPAR-γ agonist...
保存先:
| 出版年: | PPAR Res |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5937427/ https://ncbi.nlm.nih.gov/pubmed/29849538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/5346272 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|